ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)
"Biotechnologia Acta" V. 8, No 2, 2015;
https://doi.org/10.15407/biotech8.02.112
Р. 112-119, Bibliography 16, Ukrainian
Universal Decimal classification: 57.083.3 + 616-71 + 543.9
BIOANALYTICAL STANDARDIZING FOR SEROLOGICAL DIAGNOSTIC MEDICAL DEVICES
A. Yu. Galkin1, 2, A. G. Komar 3, A. A. Grigorenko 3
1National Technical University of Ukraine «Kyiv Polytechnic Institute»
2Ukrainian Medical Certification Center, Kyiv
3Ministry of Health of Ukraine, Kyiv
In article we analyzed national and international regulations concerning the quality and safety of medical devices for in vitro diagnostics. We discussed the possibility of a partial application of the recommendations of the State Pharmacopoeia of Ukraine to this type of product. The main guiding regulatory documents establishing requirements for quality and safety tools for the serological diagnosis products are The technical regulation on medical devices for the diagnosis in vitro, DSTU ISO 13485 “Medical devices. Quality management system. Regulatory requirements”, and DSTU ISO/IEC 17025 “General requirements for the competence of testing and calibration laboratories”. Similar requirements of the State Pharmacopoeia of Ukraine which are used for drug standardization can not be directly applied to the medical devises for in vitro diagnostics due to a number of features, namely, the serological diagnosis products pre-designed to determine the unknown concentration of a particular analyte in a biological material, the diagnostic kits has to include the control samples (internal standard systems) that need to be calibrated. It was determined following parameters of bioanalytical standardization and validation characterization for of qualitative (semi quantitative) test-kits for serological diagnosis: precision (convergence, intralaboratory precision and reproducibility), diagnostic and analytical specificity, diagnostic sensitivity. It’s necessary to inspect additional parameters for quantitative test-kits such as accuracy (precision), linearity, analytical sensitivity and range.
Key words: in vitro diagnostics, serological methods, analytical methods, standardization, validation.
© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2015
References
1. Zupanets I. A, Misiureva S. V., Propisnova V. V., Popov S. B., Sakharova T. S., Bezdetko N. V., Zaliubovskaia O. Y., Leonteva F. S., Tulyakov V. A. Clinical laboratory diagnostics: research methods. Zupanets I. A. (Ed.). Kharkiv: Publishing house of National Pharmacy University. 2005, P. 1–10. (In Russian).
2. Galkin O. Yu. Approaches to the synthesis of conjugates for enzyme immunoassay test-systems and evaluation of their use for diagnostics of infectious diseases. Ukrainian J. Clin. Labor. Med. 2010, 5 (4), 54–60. (In Ukrainian).
3. Technical regulations on medical products for laboratory diagnostics in vitro (approved by the Cabinet of Ministers of Ukraine of 10. 21. 2013, No. 754). Official J. Ukraine. 2013, V. 82, P. 3047. (In Ukrainian).
4. Directive 98/79/EC of the European parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Official J. Eur. Commun. 1998, L. 331, 41, P. 1.
5. DSTU 3803-98. Biotechnology. Terms and definitions. Kyiv: Derzhspozhyvstandart Ukrainy. 2007, 24 p. (In Ukrainian).
6. Schmid A., Neubauer P. Analytical biotechnology: from single molecule and single cell analyses to population dynamics of metabolites and cells. Cur. Opin. Biotechnol. 2010, 21 (1), 1–3.
http://dx.doi.org/10.1016/j.copbio.2010.02.010
7. DSTU ISO 13485:2005. Medical Products. Quality management system. Requirements for regulation. Kyiv: Derzhspozhyvstandart Ukrainy. 2007, 56 p. (In Ukrainian).
8. DSTU ISO/IEC 17025:2006. General requirements for the competence of testing and calibration laboratories. Kyiv: Derzhspozhyvstandart Ukrainy. 2007, 32 p. (In Ukrainian).
9. Nastanova ST-N MOZU 42-4.0:2014. Drugs. Good manufacturing practice (approved by the Ministry of Health of Ukraine of 07. 16. 2014, N. 497). Kyiv: Ministry of Health of Ukraine. 2014, 321 p. (In Ukrainian).
10. State Pharmacopoeia of Ukraine. First edition. Supplement 2. Hryzodub O. I. (Ed.). Kharkiv: Rireg. 2008, 617 p. (In Ukrainian).
11. DSTU ISO 14971:2009. Medical products. Guidelines for risk management. Kyiv: Derzhspozhyvstandart Ukrainy. 2009, 68 p. (In Ukrainian).
12. Currie L. A. Detection and quantification limits: origins and historical overview. Analytica Chimica Acta. 1999, 391 (2), 127–134.
http://dx.doi.org/10.1016/S0003-2670(99)00105-1
13. Thompson M., Ellison S. L. R., Wood R. Harmonized guidelines for single-laboratory validation of methods of analysis (IUPAC Technical Report). Pure Appl. Chem. 2002, 74 (5), 835–855.
http://dx.doi.org/10.1351/pac200274050835
14. Galkin O. Yu., Dugan O. M. Development of ELISA kit for the quantitative determination of total human IgM. Ukrainian J. Clin. Labor. Med. 2011, 6 (3), 181–185. (In Ukrainian).
15. Galkin A. Yu., Dugan A. M. Elaboration of immunoenzymatic test-kit for total human IgE assay and investigation of its analytical properties. Int. J. Immunol. 2013, 1 (1), 1–6.
http://dx.doi.org/10.11648/j.iji.20130101.11
16. GOST R 53022.2-2008. Clinical laboratory technology. Requirements for the quality of clinical laboratory tests. Part 2: Evaluation of reliability of analytical methods (accuracy, sensitivity, specificity). Moskva: Standartinform. 2009, 32 p. (In Russian).